Question
Technetium-99m is a radioactive isotope frequently employed in medical applications as a radioactive tracer. A radioactive tracer involves introducing an isotope into the body to facilitate the generation of diagnostic images for health condition assessment. Technetium-99m possesses a half-life of 6 hours. If a patient is administered a dose of technetium-99m in the morning, what approximate percentage of the technetium-99m will remain within the patient's body after 12 hours?(1 point)
Responses
93.8%
93.8%
12.5%
12.5%
6.25%
6.25%
25.0%
Responses
93.8%
93.8%
12.5%
12.5%
6.25%
6.25%
25.0%
Answers
GPT-4o mini
To calculate the remaining percentage of technetium-99m after 12 hours, we can use the half-life formula.
The half-life of technetium-99m is 6 hours. Therefore, after each half-life, half of the substance remains.
After 6 hours (1 half-life), 50% remains.
After 12 hours (2 half-lives), the calculation is as follows:
- Start with 100%.
- After the first half-life (6 hours): 100% / 2 = 50%.
- After the second half-life (another 6 hours): 50% / 2 = 25%.
Thus, after 12 hours, 25% of the technetium-99m will remain in the patient's body.
The correct answer is **25.0%**.
The half-life of technetium-99m is 6 hours. Therefore, after each half-life, half of the substance remains.
After 6 hours (1 half-life), 50% remains.
After 12 hours (2 half-lives), the calculation is as follows:
- Start with 100%.
- After the first half-life (6 hours): 100% / 2 = 50%.
- After the second half-life (another 6 hours): 50% / 2 = 25%.
Thus, after 12 hours, 25% of the technetium-99m will remain in the patient's body.
The correct answer is **25.0%**.
Related Questions
Technetium-99m is a radioactive isotope frequently employed in medical applications as a radioactive...
Technetium-99m is a radioactive isotope commonly used in medicine as a radioactive tracer. A radioac...
Technetium-99m is a radioactive isotope frequently employed in medical applications as a radioactive...
Technetium-99m is a radioactive isotope frequently employed in medical applications as a radioactive...